ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,175, issued on Sept. 22, was assigned to ENGREEN (Bordeaux, France) and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris).

"Chlorella-based production of extracellular vesicle-embedded small RNAs for prophylactic or therapeutic applications" was invented by Lionel Navarro (Antony, France), Khadeeja Adam Sy (Bobigny, France), Magali Charvin (Paris) and Antonio Emidio Fortunato (Bagnolet, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a novel method to produce small RNAs targeting pathogenicity factors, essential genes and/or antimicrobial resistance genes of animal pathogens. This method also includes the pr...